Sham Innovation Santé
Investor profile
Venture capital
Sham Innovation Santé has backed 3 European tech companies across 4 funding rounds between 2021 and 2022, joining rounds totalling €71M. Most active in Healthtech. Data as of Nov 2026.
Deals
4
distinct rounds
Companies
3
backed
Active span
2021–2022
2 yrs
Total round €
€71M
sum of rounds joined
Deals by year
distinct rounds / yearSham Innovation Santé — deals by year — interactive chart.
Data table
| Sham Innovation Santé — deals by year | |
|---|---|
| 2021 | 2 |
| 2022 | 2 |
Top sectors
by dealsSham Innovation Santé — top sectors — interactive chart.
Data table
| Sham Innovation Santé — top sectors | |
|---|---|
| Healthtech | 4 |
Stages
by dealsSham Innovation Santé — stages — interactive chart.
Data table
| Sham Innovation Santé — stages | |
|---|---|
| Series B | 2 |
| Seed | 1 |
| Series A | 1 |
Countries
by dealsSham Innovation Santé — countries — interactive chart.
Data table
| Sham Innovation Santé — countries | |
|---|---|
| France | 4 |
Co-investment network
shared roundsCo-investment network — interactive chart.
Hover a node for shared-deal counts; click a co-investor to open its profile.
Best viewed on a larger screen.
Frequent co-investors
shared rounds- Crédit Agricole Création2
- Elaia Partners2
- Fondation Fournier-Majoie2
- Omnes Capital2
- Simba Santé2
- CapHorn Invest1
- Crédit Mutuel Innovation1
- eureKARE1
- FundPlus1
- Go Capital1
- IDInvest Partners1
- IT-Translation1
- Kurma Partners1
- M Capital1
- Mérieux Equity Partners1
- Pertinence Invest 21
- Région Sud Investissement1
- Seroba Life Sciences1
- Sofinnova Partners1
- Théa Open Innovation1
- UI-Investissement / Pertinence Invest 21
- V-Bio Ventures1
- Verve Ventures1
Portfolio
top 30 by total round €| Company | Country | Rounds | Total € |
|---|---|---|---|
| Mablink Bioscience | France | 2 | €35M |
| Coave Therapeutics | France | 1 | €21M |
| Therapixel | France | 1 | €15M |
Biggest deals
top 10 by amount| Company | Stage | Amount | Date |
|---|---|---|---|
| Mablink Bioscience | Series A | €31M | 2022-10 |
| Coave Therapeutics | Series B | €21M | 2021-07 |
| Therapixel | Series B | €15M | 2022-05 |
| Mablink Bioscience | Seed | €4.0M | 2021-04 |